产品封面图
文献支持

D0162 抗人 CD64 抗体

收藏
  • ¥6500
  • 齐源
  • 305051
  • 国产/进口
  • 2025年07月14日
  • PG
  • 小鼠
  • 人、猴
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商

      齐源

    • 库存

      999

    • 靶点

      CD64

    • 级别

      CD64 Antibody

    • 目录编号

      CD64 Antibody

    • 克隆性

      单克隆

    • 抗原来源

      小鼠

    • 保质期

      CD64 Antibody

    • 抗体英文名

      TotalSeq™-D0162 anti-human CD64 Antibody

    • 抗体名

      CD64 Antibody

    • 标记物

      CD64 Antibody

    • 宿主

      小鼠

    • 适应物种

      人、猴

    • 免疫原

      CD64 Antibody

    • 亚型

      CD64 Antibody

    • 形态

      CD64 Antibody

    • 应用范围

      PG

    • 保存条件

      2-8℃

    • 浓度

      0.5 mg/mL

    • 规格

      10 ug

    TotalSeq™-D0162 抗人 CD64 抗体详细如下:

    Description :CD64 is a 72 kD single chain type I glycoprotein also known as FcγRI and FcR I. CD64 is amember of the immunoglobulin superfamily and is expressed on monocytes/macrophages,dendritic cells, and activated granulocytes. The expression can be upregulated by IFN-γstimulation. CD64 binds IgG immune complex. It plays a role in antigen capture, phagocytosisof IgG/antigen complexes, and antibody-dependent cellular cytotoxicity (ADCC).

    Verified Reactivity :Human, Cynomolgus, Rhesus
    Reported Reactivity :Baboon, Capuchin Monkey, Chimpanzee, Squirrel Monkey
    Antibody Type :Monoclonal
    Host Species :Mouse
    Immunogen :Human rheumatoid synovial fluid cells and fibronectin-purified monocytes.
    Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 1 mM EDTA
    Preparation :The antibody was purified by chromatography and conjugated with TotalSeq™-D oligomer underoptimal conditions.
    Concentration :0.5 mg/mL
    Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
    Application :PG - Quality tested

    Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-D antibodies arecompatible with Mission Bio’s Tapestri Single-Cell Sequencing Platform for simultaneous detectionof DNA and Protein.

    To maximize performance, it is strongly recommended that the reagent be titrated for eachapplication, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2- 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to thecell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent fortitration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™protocol for specific staining instructions.

    Buyer is solely responsible for determining whether Buyer has all intellectual property rights thatare necessary for Buyer's intended uses of the BioLegend TotalSeq™ products. For example, forany technology platform Buyer uses with TotalSeq™, it is Buyer's sole responsibility to determinewhether it has all necessary third party intellectual property rights to use that platform andTotalSeq™ with that platform.

    Application Notes :Clone 10.1 recognizes the EC3 epitope of CD64. While both contain the EC3 domain, in-housetesting suggests that clone 10.1 preferentially binds to CD64A (FcγRIA), but not CD64B (FcγRIB).Additional reported applications (for the relevant formats) include: blocking of human IgG3 andmurine IgG2a binding to FcγRI and immunohistochemical staining of a-cetone-fixed frozentissue sections .2,5,6,1112

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Application References(PubMed link indicatesBioLegend citation):

    1. McMichael A, et al. Eds. 1987. Leucocyte Typing III. Oxford University Press. New York.
    2. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York. p. 874.
    3. Kishimoto T, et al. Eds. 1997. Leucocyte Typing VI. Garland Publishing Inc. London.
    4. Holl V, et al. 2004. J. Immunol. 173:6274.
    5. Hober D, et al. 2002. J. Gen. Virol. 83:2169.
    6. Cho HJ, et al. 2007. Physiol Genomics 149:60.
    7. van Tits L, et al. 2005. Arterioscler Thromb Vasc Biol. 25:717. PubMed
    8. Bruhns P, et al. 2008. Blood 113:3716. PubMed
    9. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
    10. Carter DL, et al. 1999. Cytometry 37:41. (FC)
    11. Dougherty GJ, et al. 1987. Eur. J. Immunol. 17:1453.
    12. Blom AB, et al. 2003. Arthritis Rheum. 48(4):1002-14. (IHC)
    相关实验
    • CD64分子

      CD64 分子   CD64 常用单克隆抗体或代号: MAb32.2,MAb22;(Fcg RI) 主要表达细胞: M [M] 分子质量(kDa)和结构: gp75(IgSF) 功    能: 吞噬、ADCC,Mac活化   CD64 Aka Fc gamma RI High affinity receptor binds to Fc region of IgG

    • 抗人血清抗体的制备

      (一)材料: 1.动物:家兔 2.人血清 3.羊毛脂、石蜡油、卡介苗 4.其它:无菌生理盐水,无菌研钵等 (二)方法: 1.弗氏 佐剂 的制备 将羊毛脂与石蜡油按1:5比例混合,高压灭菌。 2.人血清——弗氏完全的制备 将灭菌 佐剂 一份置 研钵 中,边研磨边滴加等量的含卡介苗3-4mg/mL的抗原

    • 抗人肺腺癌单链抗体的构建

      抗人肺腺癌单链抗体的构建       (1)将表达载体pFUW80质粒经XbaI和EcoRI双酶切,同样双酶切在pUC19中克隆的VL基因,分别回收后,连接并转化大肠杆菌JM109株,鉴定阳性重组子(可通过XbaI、EcoRI双酶切切下合适大小的带,即VL片段)。     (2)将上述经过鉴定的重组质粒用XhoI、SpeI双酶切,回收后,与同样双酶切的在pUC19中克隆的VH基因相连,再次转化JM109感受态细菌。重组质粒筛选、鉴定同上所述。至此抗人

    图标技术资料

    需要更多技术资料 索取更多技术资料

    资料下载:

    305051.pdf 附 (下载 0 次)

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥6500
    上海齐源生物科技有限公司
    2025年07月13日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月16日询价
    询价
    艾美捷科技有限公司
    2025年07月11日询价
    ¥1050
    无锡莱弗思生物实验器材有限公司
    2025年06月29日询价
    询价
    维百奥(北京)生物科技有限公司
    2025年09月15日询价
    文献支持
    D0162 抗人 CD64 抗体
    ¥6500